Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2018

Dec 15, 2018

30786_dirs_2018-12-14_cbce2691-819a-491a-ade4-df8bf81a6251.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2018-12-14

Reporting Person: Crowley Michael (EVP, GBL Commercial Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-12-14 Bio-Rad A Common Stock S 392 $248.0297 Disposed 3425 Direct